RecruitingNCT03146936
Swiss Primary Sclerosing Cholangitis Cohort Study
Sponsor
Fondazione Epatocentro Ticino
Enrollment
120 participants
Start Date
Feb 28, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
Research project in which biological material is sampled and health-related personal data is further used and collected. Coded data are used.
Eligibility
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with cholangitis, sclerosing, psc, and other related conditions. The study is currently recruiting participants at 21 locations.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(21)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03146936
Related Trials
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
NCT069050541 location
Primary Sclerosing Cholangitis in Children
NCT0418113812 locations
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
NCT0629799318 locations
Biodegradable Stents in Primary Sclerosing Cholangitis
NCT076073531 location
Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis
NCT068659241 location